Germany’s Capiton eyes single-asset pharma deal – exclusive

Park Hill is understood to be running the process which involves omega-3 producer KD Pharma Bexbach.

16 July 2019•2 mins read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles